Abstract
The parasympathetic system (cholinergic system) is responsible for the conservation of energy, digestion, and growth. Acetylcholine is the major neurotransmitter of the parasympathetic system acting on muscarinic and nicotinic receptors. The cholinergic system can be directly stimulated by natural alkaloids like muscarine and nicotine, indirectly by inhibiting cholinesterase enzyme with carbamates. Toxins like bungarotoxins, conotoxin, and botulinum toxin inhibit cholinergic neurotransmission. Modulation of acetylcholine level by various acetylcholinesterase inhibitors plays a pivot role in the management of neurodegenerative disorders like Alzheimer’s disease, glaucoma, snakebite envenomation, and others. Understanding the mechanism of inhibition of acetylcholinesterases by organophosphorus compounds, carbamates, and nerve gases has led to successful pharmacological management of poisoning by these compounds. This chapter will review the synthesis and secretion of ACh, its receptors and actions brought out by the cholinergic system with details about the drugs that modulate the cholinergic system for the benefit in various clinical conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Carnevali L, Sgoifo A (2014) Vagal modulation of resting heart rate in rats: the role of stress, psychosocial factors, and physical exercise. Front Physiol 5:118
Conn PJ, Jones CK, Lindsley CW (2009) Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Trends Pharmacol Sci 30(3):148–155
Eddleston M, Chowdhury FR (2016) Pharmacological treatment of organophosphorus insecticide poisoning: the old and the (possible) new. Br J Clin Pharmacol 81(3):462–470
Eddleston M, Eyer P, Worek F, Juszczak E, Alder N, Mohamed F et al (2009) Pralidoxime in acute organophosphorus insecticide poisoning--a randomised controlled trial. PLoS Med 6(6):e1000104
Eglen RM, Hegde SS, Watson N (1996) Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 48(4):531–565
Felder CC, Bymaster FP, Ward J, DeLapp N (2000) Therapeutic opportunities for muscarinic receptors in the central nervous system. J Med Chem 43(23):4333–4353
Köppel C (1993) Clinical symptomatology and management of mushroom poisoning. Toxicon 31(12):1513–1540
Kruse AC, Hu J, Pan AC, Arlow DH, Rosenbaum DM, Rosemond E et al (2012) Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 482(7386):552–556
Langmead CJ, Watson J, Reavill C (2008) Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol Ther 117(2):232–243
Lanzafame AA, Christopoulos A, Mitchelson F (2003) Cellular signaling mechanisms for muscarinic acetylcholine receptors. Recept Channels 9(4):241–260
Matsui M, Motomura D, Fujikawa T, Jiang J, Takahashi S, Manabe T et al (2002) Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J Neurosci 22(24):10627–10632
Romano MC, Doan HK, Poppenga RH, Filigenzi MS, Bryant UK, Gaskill CL (2019) Fatal amanita muscaria poisoning in a dog confirmed by PCR identification of mushrooms. J Vet Diagn Investig 31(3):485–487
Wess J (1996) Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 10(1):69–99
Yin X, Yang A-A, Gao J-M (2019) Mushroom toxins: chemistry and toxicology. J Agric Food Chem 67(18):5053–5071
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Lakshmanan, M. (2021). Cholinoceptor Agonists and Anticholinesterase Agents. In: Paul, A., Anandabaskar, N., Mathaiyan, J., Raj, G.M. (eds) Introduction to Basics of Pharmacology and Toxicology. Springer, Singapore. https://doi.org/10.1007/978-981-33-6009-9_1
Download citation
DOI: https://doi.org/10.1007/978-981-33-6009-9_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-6008-2
Online ISBN: 978-981-33-6009-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)